Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
4,612
datasets available to search
ShareScore release 0.9.0
Dataset results
4,612 results for “Labels”
A Study to Assess the Effects of Dissolution Profile on the Pharmacokinetics of Single Oral Doses of Tafenoquine Tablets and Tafenoquine Stable Isotope Labelled Solution
ClinicalTrials.gov study NCT02751294. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Enhanced Spanish Drug Label Study to Promote Patient Understanding and Use
ClinicalTrials.gov study NCT01200849. IPD Sharing: Not stated. Countries: 1. Publications: 1.
An Open-label Extension to Assess the Continued Efficacy of Omacor Plus Simvastatin
ClinicalTrials.gov study NCT00678743. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Open Label Randomized Clinical Trial to Assess the Safety of Teleconsultation
ClinicalTrials.gov study NCT05094180. IPD Sharing: NO. Countries: 1. Publications: 1.
Effect of Concurrent Capecitabine-based Long-term Radiotherapy Followed by XELOX Plus TME in Patients With High Risk Rectal Cancer: a Multi-centers, Randomized Controlled, Open-Label Trial
ClinicalTrials.gov study NCT03038256. IPD Sharing: YES. Countries: 1. Publications: 10.
Open-Label Placebo Treatment for Acute Postoperative Pain
ClinicalTrials.gov study NCT04339023. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Augmentation in Tx-resistant OCD: an Open Label Trial
ClinicalTrials.gov study NCT00590642. IPD Sharing: Not stated. Countries: 1. Publications: 17.
Phase I Open-Label Dose Finding Study of SGN-35 for CD30 Positive Hematologic Malignancies
ClinicalTrials.gov study NCT00430846. IPD Sharing: Not stated. Countries: 1. Publications: 2.
An Open-label Safety, Tolerability, and Dose-range Finding Study of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA)
ClinicalTrials.gov study NCT01494701. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Open-label, Multicenter Immunogenicity and Safety Study of MVA-BN Vaccine in Children From 2 Years to Less Than 12 Years of Age Compared to Adults for the Prevention of Smallpox, Mpox, and Related Ort
ClinicalTrials.gov study NCT06549530. IPD Sharing: NO. Countries: 2. Publications: 0.
Positron Nuclide Labeled NOTA-FAPI PET Study in Lymphoma
ClinicalTrials.gov study NCT04367948. IPD Sharing: NO. Countries: 1. Publications: 2.
A Multi-Center, Open-label Study Evaluate the Efficacy and Tolerability of a Dual Skincare Regimen Treatment for Facial Hyperpigmentation and Photodamaged Skin in Patients Exposed to Extrinsic Factors
ClinicalTrials.gov study NCT05423873. IPD Sharing: Not stated. Countries: 1. Publications: 1.
An Open Label Study of Severe Sepsis in Adults
ClinicalTrials.gov study NCT00568893. IPD Sharing: Not stated. Countries: 1. Publications: 1.
An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease
ClinicalTrials.gov study NCT05522387. IPD Sharing: NO. Countries: 1. Publications: 42.
An Open-label Extension Trial to Evaluate the Long-term Safety of KVD900 (Sebetralstat) for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult Patients With Hereditary Angioedema (HAE)
ClinicalTrials.gov study NCT05505916. IPD Sharing: NO. Countries: 23. Publications: 2.
Study to Evaluate the Safety, Tolerability,Pharmacokinetics, and Antitumor Activity of a Thorium-227 Labeled Antibody-chelator Conjugate Alone and in Combination With Darolutamide, in Patients With Me
ClinicalTrials.gov study NCT03724747. IPD Sharing: NO. Countries: 3. Publications: 1.
Open Label Trial on the Safety and Efficacy of Sym001 in the Treatment of Immune Thrombocytopenic Purpura (ITP)
ClinicalTrials.gov study NCT00718692. IPD Sharing: NO. Countries: 12. Publications: 1.
A Single-arm, Open-label Study of Olverembatinib, CD3/CD19 Bispecific T-cell Engager, and Chidamide in Patients With Newly Diagnosed Ph+ALL
ClinicalTrials.gov study NCT06220487. IPD Sharing: Not stated. Countries: 1. Publications: 2.
An Open-label, Clinical Feasibility Study of the Efficacy of Remdesivir for Long-COVID.
ClinicalTrials.gov study NCT05911906. IPD Sharing: YES. Countries: 1. Publications: 0.
Open-Label, Single-Dose Study to Evaluate the Safety and PK of DIC075V in Subjects With Renal Insufficiency and Hepatic Impairment Compared to Healthy Subjects and Evaluate the Safety and Pharmacokine
ClinicalTrials.gov study NCT00805090. IPD Sharing: Not stated. Countries: 2. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.